1-20 of 36
Eline Menu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exosomes in multiple myeloma: from bench to bedside

Eline Menu, Karin Vanderkerken
Journal: Blood
Blood (2022) 140 (23): 2429–2442.
https://doi.org/10.1182/blood.2021014749
Published: 2022
Journal Articles

Inhibition of Oxidative Phosphorylation and Glycolysis Reduces Viability in Multiple Myeloma By Affecting mTOR-Mediated Protein Synthesis

Inge Oudaert, Arne Van der Vreken, Gamze Ates, Sylvia Faict, Philip Vlummens, Hatice Satilmis, Rong Fan, Anke Maes, Elke De Bruyne, Kim De Veirman, Ann Massie, Karin Vanderkerken, Eline Menu
Journal: Blood
Blood (2022) 140 (Supplement 1): 7078–7079.
https://doi.org/10.1182/blood-2022-167025
Published: 2022
Journal Articles

Pyrroline-5-Carboxylate Reductase 1: A Novel Target for Sensitizing Myeloma to Cytotoxic Agents By Inhibition of PRAS40-Mediated Protein Synthesis

Inge Oudaert, Hatice Satilmis, Philip Vlummens, Anke Maes, Elke De Bruyne, Karin Vanderkerken, Sarah-Maria Fendt, Kim De Veirman, Eline Menu
Journal: Blood
Blood (2021) 138 (Supplement 1): 1574.
https://doi.org/10.1182/blood-2021-149156
Published: 2021
Journal Articles

Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo

Rong Fan, Hatice Satilmis, Niels Vandewalle, Elke De Bruyne, Eline Menu, Andrew D Chantry, Holly Evans, Marie Törngren, Helena Eriksson, Karine Breckpot, Ken Maes, Karin Vanderkerken, Kim De Veirman
Journal: Blood
Blood (2021) 138 (Supplement 1): 1594.
https://doi.org/10.1182/blood-2021-147744
Published: 2021
Journal Articles

MCL1 Inhibitors in Multiple Myeloma

Karin Vanderkerken, PhD, Kim De Veirman, Ken Maes, Eline Menu, PhD, Elke De Bruyne, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): SCI-12.
https://doi.org/10.1182/blood-2019-121104
Published: 2019
Journal Articles

Receptor Tyrosine Kinase AXL: A Potential Strategy to Counter Immune Suppression and Dormancy in Multiple Myeloma

Kim De Veirman, Siyang Yan, Ken Maes, Nathan De Beule, MD, Sylvia Faict, MSc, Elke De Bruyne, PhD, Eline Menu, PhD, Karin Vanderkerken, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4335.
https://doi.org/10.1182/blood-2019-126834
Published: 2019
Journal Articles

The Exosomal Transfer of Acid Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma

Inge Oudaert, MSc, Sylvia Faict, MSc, Ludovic D'Auria, PhD, Jonas Dehairs, PhD, Ken Maes, Philip Vlummens, MD, Lotte Jacobs, BSc, Kim De Veirman, Elke De Bruyne, PhD, Karel Fostier, MD, Isabelle Vande Broek, MD PhD, Rik Schots, Karin Vanderkerken, PhD, Johannes V. Swinnen, PhD, Eline Menu, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3058.
https://doi.org/10.1182/blood-2019-122857
Published: 2019
Journal Articles

Exosomes Play a Key Role in Multiple Myeloma Bone Disease and Tumor Development

Sylvia Faict, MD, Josephine Muller, PhD, Kim De Veirman, PhD, Ken Maes, Elke De Bruyne, PhD, Rik Schots, Jo Caers, MD PhD, Karin Vanderkerken, PhD, Eline Menu, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4484.
https://doi.org/10.1182/blood-2018-99-112428
Published: 2018
Journal Articles

Histone Methyltransferases G9a and GLP; Identification and Validation of Novel Therapeutic Targets for Multiple Myeloma Treatment

Eva De Smedt, Julie Devin, Hui Liu, Anke Maes, Ken Maes, Kim De Veirman, Eline Menu, PhD, Karin Vanderkerken, PhD, Jerome Moreaux, PhD, Elke De Bruyne, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4356.
https://doi.org/10.1182/blood.V130.Suppl_1.4356.4356
Published: 2017
Journal Articles

The Anaphase Promoting Complex/Cyclosome: A New Promising Target in Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma

Anke Maes, Eva De Smedt, Kim De Veirman, Ken Maes, Eline Menu, PhD, Els Van Valckenborgh, PhD, Karin Vanderkerken, PhD, Elke De Bruyne, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2757.
https://doi.org/10.1182/blood.V130.Suppl_1.2757.2757
Published: 2017
Journal Articles

Targeting S100A9 Interactions in the Multiple Myeloma Bone Marrow Environment Reduces Angiogenesis and Tumor Growth

Kim De Veirman, PhD, Els Van Valckenborgh, PhD, Nathan De Beule, MD, Hendrik De Raeve, Ken Maes, PhD, Elke De Bruyne, PhD, Eline Menu, PhD, Karin Vanderkerken, PhD
Journal: Blood
Blood (2016) 128 (22): 3248.
https://doi.org/10.1182/blood.V128.22.3248.3248
Published: 2016
Journal Articles

The Crosstalk Between Leptin Receptor Activation and iNKT Mediated Anti-Tumor Immunity in Multiple Myeloma

Mérédis Favreau, PhDstudent, Eline Menu, PhD, Karin Vanderkerken, PhD, Sylvia Faict, MD, Ken Maes, PhD, Els Van Valckenborgh, PhD, Elke De Bruyne, PhD, Srinath Govindarajan, PhDstudent, Michael Drennan, PhD, Xavier Leleu, Lennart Zabeau, PhD, Jan Tavernier, PhD, Koen Venken, PhD, Dirk Elewaut, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2075.
https://doi.org/10.1182/blood.V128.22.2075.2075
Published: 2016
Journal Articles

The Src Inhibitor AZD0530 Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma

Roy Heusschen, PhD, Joséphine Muller, MSc, Marilène Binsfeld, MSc, Erwan Plougonven, PhD, Nadia Mahli, BSc, Geert Carmeliet, MD PhD, Angélique Léonard, PhD, Martine Cohen-Solal, MD PhD, Karin Vanderkerken, PhD, Yves Beguin, MD PhD, Eline Menu, PhD, Jo Caers, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3018.
https://doi.org/10.1182/blood.V126.23.3018.3018
Published: 2015
Journal Articles

The in vivo Transcriptional Response Towards Epigenetic Modulating Agents in Multiple Myeloma

Ken Maes, Eva De Smedt, Kassambara Alboukadel, PhD, Dirk Hose, MD PhD, Anja Seckinger, MD PhD, Els Van Valckenborgh, PhD, Eline Menu, PhD, Bernard Klein, MD PhD, Karin Vanderkerken, PhD, Jerome Moreaux, PhD, Elke De Bruyne, PhD
Journal: Blood
Blood (2014) 124 (21): 3375.
https://doi.org/10.1182/blood.V124.21.3375.3375
Published: 2014
Journal Articles

Targeting the Anaphase Promoting Complex/Cyclosome (APC/C) in Multiple Myeloma

Susanne Lub, Anke Maes, Ken Maes, Kim De Veirman, Xavier Leleu, MD PhD, Eline Menu, PhD, Elke De Bruyne, PhD, Karin Vanderkerken, PhD, Els Van Valckenborgh, PhD
Journal: Blood
Blood (2014) 124 (21): 2097.
https://doi.org/10.1182/blood.V124.21.2097.2097
Published: 2014
Journal Articles

Myeloid Derived Suppressor Cell Mediated AMPK Activation Regulates Multiple Myeloma Cell Survival

Kim De Veirman, Jo A. Van Ginderachter, Ivan Van Riet, Nathan De Beule, Susanne Lub, Eline Menu, PhD, Elke De Bruyne, PhD, Karin Vanderkerken, PhD, Els Van Valckenborgh, PhD
Journal: Blood
Blood (2014) 124 (21): 2009.
https://doi.org/10.1182/blood.V124.21.2009.2009
Published: 2014
Journal Articles

Bone marrow stromal cell–derived exosomes as communicators in drug resistance in multiple myeloma cells

Jinheng Wang, An Hendrix, Sophie Hernot, Miguel Lemaire, Elke De Bruyne, Els Van Valckenborgh, Tony Lahoutte, Olivier De Wever, Karin Vanderkerken, Eline Menu
Journal: Blood
Blood (2014) 124 (4): 555–566.
https://doi.org/10.1182/blood-2014-03-562439
Published: 2014
Includes: Supplemental data
Journal Articles

Bone Marrow Stromal Cell-Derived Exosomes Facilitate Multiple Myeloma Cell Survival Through Inhibition Of The JNK Pathway

Jinheng Wang, An Hendrix, PhD, Elke De Bruyne, PhD, Els Van Valckenborgh, PhD, Eddy Himpe, Nathan De Beule, MD, Olivier De Wever, PhD, Karin Vanderkerken, Eline Menu, PhD
Journal: Blood
Blood (2013) 122 (21): 679.
https://doi.org/10.1182/blood.V122.21.679.679
Published: 2013
Journal Articles

Dll1/Notch Interaction Contributes to a Decreased Sensitivity of Myeloma Cells to Bortezomib

Dehui Xu, Jingsong Hu, Elke De Bruyne, PhD, Eline Menu, PhD, Rik Schots, MD, Karin Vanderkerken, PhD, Els Van Valckenborgh, PhD
Journal: Blood
Blood (2012) 120 (21): 1840.
https://doi.org/10.1182/blood.V120.21.1840.1840
Published: 2012
Journal Articles

The DNA Methyltransferase Inhibitor Decitabine Induces DNA Damage, Cell Cycle Arrest and Apoptosis in Multiple Myeloma

Ken Maes, Miguel Lemaire, Jordan Gauthier, Hendrik De Raeve, Eline Menu, PhD, Els Van Valckenborgh, PhD, Helena Jernberg Wiklund, PhD, Karin Vanderkerken, PhD, Elke De Bruyne, PhD
Journal: Blood
Blood (2012) 120 (21): 1833.
https://doi.org/10.1182/blood.V120.21.1833.1833
Published: 2012